ENVOY MEDICAL INC (COCH) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:COCH • US29415V1098

0.525 USD
-0.05 (-8.73%)
Last: Feb 5, 2026, 10:51 AM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to COCH. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 8.42. This target is 1502.86% above the current price.
  • COCH was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about COCH.
  • In the previous month the buy percentage consensus was at a similar level.
  • COCH was analyzed by 7 analysts. More opinions would make the average more meaningful.
COCH Historical Analyst RatingsCOCH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -24 -22 -20 -18 -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.537.078.428.429.98 - 1,246.67% 1,502.86% 1,502.86% 1,800.00%
COCH Current Analyst RatingCOCH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2025-05-27 Ascendiant Capital Maintains Buy -> Buy
2025-04-21 Ascendiant Capital Maintains Buy -> Buy
2024-12-06 Ascendiant Capital Maintains Buy -> Buy
2024-10-14 Brookline Capital Initiate Buy
2024-09-03 Ascendiant Capital Maintains Buy -> Buy
2024-06-24 Ascendiant Capital Initiate Buy
2024-04-03 Lake Street Maintains Buy -> Buy
2023-12-21 Northland Capital Markets Initiate Outperform
2023-11-28 Lake Street Initiate Buy

ENVOY MEDICAL INC / COCH FAQ

Can you provide the average price target for ENVOY MEDICAL INC stock?

7 analysts have analysed COCH and the average price target is 8.41 USD. This implies a price increase of 1502.86% is expected in the next year compared to the current price of 0.525.


What is the consensus rating for COCH stock?

The consensus rating for ENVOY MEDICAL INC (COCH) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.